India will produce more than 100 million doses a year of the vaccine against Russia’s coronavirus disease (Covid-19) Sputnik V starting in 2021 following an agreement between Russia’s Direct Investment Fund (RDIF) and Hetero Biopharma, with headquarters in Hyderabad. Sputnik V is based on a well-studied platform of human adenoviral …
Read More »Covid-19: Starting in 2021, India will produce 100 million doses of Russian Sputnik V vaccine
